» Articles » PMID: 23550645

Mir-17-92: a Polycistronic Oncomir with Pleiotropic Functions

Overview
Journal Immunol Rev
Date 2013 Apr 5
PMID 23550645
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Neoplastic transformation is caused by accumulation of genetic lesions that ultimately convert normal cells into tumor cells with uncontrolled proliferation and survival, unlimited replicative potential, and invasive growth. Emerging evidence has highlighted the functional importance of non-coding RNAs, particularly microRNAs (miRNAs), in the initiation and progression of tumor development. The mir-17-92 miRNA is among the best characterized miRNA oncogenes, whose genomic amplification or aberrant elevation are frequently observed in a variety of tumor types. Unlike protein-coding oncogenes, where one transcript produces one protein, mir-17-92 encodes a polycistronic miRNA transcript that yields six individual miRNA components. This unique gene structure, shared by many important miRNA oncogenes and tumor suppressors, underlies the unique functionality of mir-17-92 in a cell type and context-dependent manner. Recent functional dissection of mir-17-92 indicates that individual mir-17-92 components perform distinct biological functions, which collectively regulate multiple related cellular processes during development and disease. The structural complexity of mir-17-92 as a polycistronic miRNA oncogene, along with the complex mode of interactions among its components, constitutes the molecular basis for its unique functional complexity during normal and tumor development.

Citing Articles

The TGFβ Induced MicroRNAome of the Trabecular Meshwork.

Doyle C, Callaghan B, Roodnat A, Armstrong L, Lester K, Simpson D Cells. 2024; 13(12.

PMID: 38920689 PMC: 11201560. DOI: 10.3390/cells13121060.


Elucidation of how the Mir-23-27-24 cluster regulates development and aging.

Yap X, Chen J Exp Mol Med. 2024; 56(6):1263-1271.

PMID: 38871817 PMC: 11263685. DOI: 10.1038/s12276-024-01266-3.


MicroRNA-19 is regulated by aldosterone in a sex-specific manner to alter kidney sodium transport.

Farrell C, Liu X, Yagan N, Suda A, Cerqueira D, Bodnar A Am J Physiol Cell Physiol. 2023; 326(1):C282-C293.

PMID: 38047299 PMC: 11192485. DOI: 10.1152/ajpcell.00385.2023.


Editorial: Genes, diseases, immunity and immunogenomics.

Siddique H Front Genet. 2023; 14:1218084.

PMID: 37347057 PMC: 10280735. DOI: 10.3389/fgene.2023.1218084.


SRSF3 shapes the structure of miR-17-92 cluster RNA and promotes selective processing of miR-17 and miR-20a.

Ratnadiwakara M, Bahrudeen M, Aikio E, Takabe P, Engel R, Zahir Z EMBO Rep. 2023; 24(7):e56021.

PMID: 37306233 PMC: 10328067. DOI: 10.15252/embr.202256021.


References
1.
Zamore P, Haley B . Ribo-gnome: the big world of small RNAs. Science. 2005; 309(5740):1519-24. DOI: 10.1126/science.1111444. View

2.
Shan S, Lee D, Deng Z, Shatseva T, Jeyapalan Z, Du W . MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol. 2009; 11(8):1031-8. DOI: 10.1038/ncb1917. View

3.
Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T . miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci. 2011; 102(12):2264-71. DOI: 10.1111/j.1349-7006.2011.02081.x. View

4.
Mu P, Han Y, Betel D, Yao E, Squatrito M, Ogrodowski P . Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009; 23(24):2806-11. PMC: 2800095. DOI: 10.1101/gad.1872909. View

5.
Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A . Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J. 2011; 30(21):4450-64. PMC: 3230374. DOI: 10.1038/emboj.2011.317. View